Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by thediggeron Jan 09, 2018 8:42am

190 Views

Post# 27311715

NF could have the same surge then HIP

A licence issued to NHS (which is coming pretty fast), a supply agreement between NHS and WAK and WAK to start selling its products in BC. Then BOOM! My feeling is the Monday's PR was not directed to us but to HC which is speeding up the process to increase the LP number to 200. A rumor has been circulating that HC met Monday to start speeding up this process...

Bullboard Posts

Changing Europe’s dependency on HREE from China